Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• PolireddyKChenQCancer of the pancreas: molecular pathways and current advancement in treatmentJ Cancer20167111497151427471566
   PubMed Web of Science ®Google Scholar
• WolfgangCLHermanJMLaheruDARecent progress in pancreatic cancerCA Cancer J Clin201363531834823856911
   PubMed Web of Science ®Google Scholar
• GillenSSchusterTMeyerZBCFriessHKleeffJPreoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentagesPLoS Med201074e100026720422030
   PubMed Web of Science ®Google Scholar
• TaiebJPointetALVan LaethemJLWhat treatment in 2017 for inoperable pancreatic cancersAnn Oncol20172871473148328459988
   PubMed Web of Science ®Google Scholar
• MoriRIshikawaTIchikawaYHuman equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cellsOncol Rep20071751201120517390066
   PubMed Web of Science ®Google Scholar
• SaikiYYoshinoYFujimuraHDCK is frequently inactivated in acquired gemcitabine-resistant human cancer cellsBiochem Biophys Res Commun201242119810422490663
   PubMed Web of Science ®Google Scholar
• CividiniFFiloniDNPesiRAllegriniSCamiciMTozziMGIMP-GMP specific cytosolic 5′-nucleotidase regulates nucleotide pool and prodrug metabolismBiochim Biophys Acta2015185071354136125857773
   PubMed Web of Science ®Google Scholar
• SerdjebiCSeitzJFCiccoliniJRapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimenPharmacogenomics20131491047105123837479
   PubMed Web of Science ®Google Scholar
• HungSWMarracheSCumminsSDefective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approachCancer Lett2015359223324025600708
   PubMed Web of Science ®Google Scholar
• ZhaoXWangXSunWPrecision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatmentBiomaterials2018158445529275122
   PubMed Web of Science ®Google Scholar
• MackeyJRManiRSSelnerMFunctional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell linesCancer Res19985819434943579766663
   PubMed Web of Science ®Google Scholar
• DamarajuVLDamarajuSYoungJDNucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapyOncogene200322477524753614576856
   PubMed Web of Science ®Google Scholar
• KoczorCATorresRALewisWThe role of transporters in the toxicity of nucleoside and nucleotide analogsExpert Opin Drug Metab Toxicol20128666567622509856
   PubMed Web of Science ®Google Scholar
• BinenbaumYNa’araSGilZGemcitabine resistance in pancreatic ductal adenocarcinomaDrug Resist Updat201523556826690340
   PubMed Web of Science ®Google Scholar
• MiniENobiliSCaciagliBLandiniIMazzeiTCellular pharmacology of gemcitabineAnn Oncol200617suppl 5v7v1216807468
   PubMed Web of Science ®Google Scholar
• SpratlinJSanghaRGlubrechtDThe absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinomaClin Cancer Res200410206956696115501974
   PubMed Web of Science ®Google Scholar
• YamadaRMizunoSUchidaKHuman equilibrative nucleoside transporter 1 expression in endoscopic ultrasonography-guided fine-needle aspiration biopsy samples is a strong predictor of clinical response and survival in the patients with pancreatic ductal adenocarcinoma undergoing gemcitabine-based chemoradiotherapyPancreas201645576177126784908
   PubMed Web of Science ®Google Scholar
• YuXDiYXieCAn in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell lineInt J Nanomedicine2015106825683426586944
   PubMed Web of Science ®Google Scholar
• KaksonenMRouxAMechanisms of clathrin-mediated endocytosisNat Rev Mol Cell Biol201819531332629410531
   PubMed Web of Science ®Google Scholar
• DohertyGJMcMahonHTMechanisms of endocytosisAnnu Rev Biochem20097885790219317650
   PubMed Web of Science ®Google Scholar
• ShimadaTNakanishiTTajimaHSaturable hepatic extraction of gemcitabine involves biphasic uptake mediated by nucleoside transporters equilibrative nucleoside transporter 1 and 2J Pharm Sci201510493162316926037416
   PubMed Web of Science ®Google Scholar
• LiTDongZRGuoZYAspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathwayCancer Gene Ther201320636637423703473
   PubMed Web of Science ®Google Scholar
• KastanMBBartekJCell-cycle checkpoints and cancerNature2004432701531632315549093
   PubMed Web of Science ®Google Scholar
• HotchkissRSStrasserAMcDunnJESwansonPECell deathN Engl J Med2009361161570158319828534
   PubMed Web of Science ®Google Scholar
• WangHWordBRLyn-CookBDEnhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1Anticancer Res201131103171318021965724
   PubMed Web of Science ®Google Scholar
• Makohon-MooreAIacobuzio-DonahueCAPancreatic cancer biology and genetics from an evolutionary perspectiveNat Rev Cancer201616955356527444064
   PubMed Web of Science ®Google Scholar
• HidalgoMPancreatic cancerN Engl J Med2010362171605161720427809
   PubMed Web of Science ®Google Scholar
• JungJSeolHSChangSThe generation and application of patient-derived xenograft model for cancer researchCancer Res Treat201850111028903551
   PubMed Web of Science ®Google Scholar
• LaiYWeiXLinSQinLChengLLiPCurrent status and perspectives of patient-derived xenograft models in cancer researchJ Hematol Oncol201710110628499452
   PubMedGoogle Scholar